Enhanced dissolution characteristics of piroxicam–Soluplus® nanosuspensions

References

• Guidance for industry waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. U.S. Department of Health and Human Services, FDA; 2000. Available from: http://www.fda.gov/cder/guidance/index.htm
   Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59:603–616.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, et al. Preparation and characterisation of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery. Int J Pharm. 2005;298:55–67.
   PubMed Web of Science ®Google Scholar
• Choonara YE, Pillay V, Ndesendo MKV, et al. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids Surf B Biointerfaces. 2011; 87:243–254.
   Google Scholar
• Taupitz T, Dressman JB, Buchanan CM, et al. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. Eur J Pharm Biopharm. 2013;83:378–87.
   PubMed Web of Science ®Google Scholar
• Müller RH, Keck, CM. Twenty years of drug nanocrystals: where are we, and where do we go? Eur J Pharm Biopharm. 2012;80:1–3.
   PubMed Web of Science ®Google Scholar
• Lai F, Pini E, Angioni G, et al. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets. Eur J Pharm Biopharm. 2011;79:552–558.
   PubMed Web of Science ®Google Scholar
• Lai F, Pini E, Corrias F, et al. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying. Int J Pharm. 2014;467:27–33.
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date A, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827–840.
   PubMed Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Li L, et al. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int J Pharm. 2010;383:285–292.
   PubMed Web of Science ®Google Scholar
• Ghosh I, Michniak-Kohn B. Design and characterization of submicron formulation for a poorly soluble drug: the effect of vitamin E TPGS and other solubilizers on skin permeability enhancement. Int J Pharm. 2012;434:90–98.
   PubMed Web of Science ®Google Scholar
• Bhakay A, Merwade M, Bilgili E, et al. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs. Drug Dev Ind Pharm. 2011;37:963–976.
   PubMed Web of Science ®Google Scholar
• Rezaei Mokarram A, Kebriaee Zadeh A, Keshavarz M, et al. Preparation and in-vitro evaluation of indomethacin nanoparticles. Daru. 2010;18:185–192.
   PubMed Web of Science ®Google Scholar
• Araújo J, Gonzalez E, Egea MA, et al. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine. 2009;5:394–401.
   PubMed Web of Science ®Google Scholar
• BASF. Technical information Soluplus. BASF, Pharma Ingredients Serv. 2010;1–8. Available from: https://industries.basf.com/en/documentDownload.8805242743253.Soluplus%C2%AE%20-%20Technical%20Information.pdf
   Google Scholar
• Reintjes T. Solubility enhancement with BASF pharma polymers: solubilizer compendium. Lampertheim: BASF SE, Pharma Ingredients and Services; 2011.
   Google Scholar
• George M, Ghosh I. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci. 2013;48:142–152.
   PubMed Web of Science ®Google Scholar
• Maulvi FA, Dalwadi SJ, Thakkar VT, et al. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol. 2011; 207:47–54.
   Google Scholar
• Karataş A, Yüksel N, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Farmaco. 2005;60:777–782.
   PubMedGoogle Scholar
• Sethia S, Squillante E. In vitro–in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells. J Pharm Sci. 2004;93:2985–2993.
   PubMed Web of Science ®Google Scholar
• Boulenc X, Roques C, Joyeux H, et al. Bisphosphonates increase tight junction permeability in the human intestinal epithelial (Caco-2) model. Int J Pharm. 1995;123:13–24.
   Web of Science ®Google Scholar
• Linn M, Collnot E-M, Djuric D, et al. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 2012;45:336–343.
   PubMed Web of Science ®Google Scholar
• Kim M-S. Soluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugs. Artif Cells Nanomed Biotechnol. 2013;41:363–367.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2012;64:163–174.
   Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67:217–223.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
   Web of Science ®Google Scholar